Dhaka, April 22 -- Bangladesh's transition out of the Least Developed Countries (LDC) bracket to a developing nation will bring several challenges for the pharmaceutical industry, sector insiders fear.

Speaking at a workshop in Dhaka on Monday, participants said certain benefits currently enjoyed by the industry will no longer be available post-graduation while competition with foreign companies is expected to intensify.

The event, titled "Journey of Bangladesh Pharmaceutical Industry", was held in Tejgaon and jointly organised by the Bangladesh Association of Pharmaceutical Industries (BAPI) and the Bangladesh Health Reporters Forum.

Md Zakir Hossain, secretary general of BAPI, presented an overview of the sector and its current posit...